ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1047
0,00%
Bitcoin
67.013,22
-0,10%
Brent Oil
83,76
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Kosan Biosciences (MM) (KOSN)

  7. Kosan Biosciences (MM) (KOSN) Notícias

KOSN

Kosan Biosciences (MM) (KOSN)

Kosan Biosciences (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:KOSN
DataHoraFonteTítuloCódigoCompanhia
26/06/200818:39Business WireBristol-Myers Squibb Completes Acquisition of Kosan Biosciences IncorporatedNASDAQ:KOSNKosan Biosciences (MM)
26/06/200817:34Edgar (US Regulatory)Kosan Biosciences Inc - Termination of Registration of a Class of Security under Section 12(g) (15-12G)NASDAQ:KOSNKosan Biosciences (MM)
26/06/200817:20Edgar (US Regulatory)Kosan Biosciences Inc- (25-NSE)NASDAQ:KOSNKosan Biosciences (MM)
26/06/200814:36Edgar (US Regulatory)Kosan Biosciences Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:KOSNKosan Biosciences (MM)
26/06/200811:08Edgar (US Regulatory)Kosan Biosciences Inc - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:KOSNKosan Biosciences (MM)
03/06/200811:00PR Newswire (US)Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive BreasNASDAQ:KOSNKosan Biosciences (MM)
30/05/200810:33MarketwiredWall Street News Alert: Stocks on the Move for Friday: CPYE! May 30, 2008NASDAQ:KOSNKosan Biosciences (MM)
30/05/200808:15MarketwiredEquity Spotlight for Friday, May 30, 2008: MDII Additional Product Order!NASDAQ:KOSNKosan Biosciences (MM)
29/05/200817:36Edgar (US Regulatory)Kosan Biosciences Inc - Statement of Ownership: Solicitation (SC 14D9)NASDAQ:KOSNKosan Biosciences (MM)
29/05/200817:23Edgar (US Regulatory)Kosan Biosciences Inc - Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:KOSNKosan Biosciences (MM)
29/05/200815:20Business WireBristol-Myers Squibb Begins Tender Offer to Acquire Kosan Biosciences Inc.NASDAQ:KOSNKosan Biosciences (MM)
29/05/200814:30Edgar (US Regulatory)Kosan Biosciences Inc - Tender offer statement by Third Party (SC TO-T)NASDAQ:KOSNKosan Biosciences (MM)
29/05/200813:32Edgar (US Regulatory)Kosan Biosciences Inc - Current report filing (8-K)NASDAQ:KOSNKosan Biosciences (MM)
29/05/200812:06MarketwiredBellwetherReport.com Analyst Report on KOSN, ACEL, SHLD and SSCCNASDAQ:KOSNKosan Biosciences (MM)
29/05/200809:22Business WireBristol-Myers Squibb to Acquire Kosan BiosciencesNASDAQ:KOSNKosan Biosciences (MM)
28/05/200814:27Edgar (US Regulatory)Kosan Biosciences Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:KOSNKosan Biosciences (MM)
20/05/200807:00PR Newswire (US)Kosan Appoints Pamela S. Cohen, M.D., as Chief Medical OfficerNASDAQ:KOSNKosan Biosciences (MM)
14/05/200807:00PR Newswire (US)Kosan Announces Data Presentations at ASCO 2008 Annual MeetingNASDAQ:KOSNKosan Biosciences (MM)
12/05/200817:52Edgar (US Regulatory)Kosan Biosciences Inc - Quarterly Report (10-Q)NASDAQ:KOSNKosan Biosciences (MM)
06/05/200817:00PR Newswire (US)Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable ConferenceNASDAQ:KOSNKosan Biosciences (MM)
01/05/200818:00PR Newswire (US)Kosan Announces First Quarter 2008 Financial ResultsNASDAQ:KOSNKosan Biosciences (MM)
25/04/200808:00PR Newswire (US)Kosan Announces May 1, 2008 Conference Call and Webcast of First Quarter 2008 Financial ResultsNASDAQ:KOSNKosan Biosciences (MM)
24/04/200807:08Edgar (US Regulatory)Kosan Biosciences Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:KOSNKosan Biosciences (MM)
16/04/200818:09PR Newswire (US)Kosan Presents Preclinical Data on Novel Third-Generation Hsp90 Inhibitors at AACRNASDAQ:KOSNKosan Biosciences (MM)
16/04/200818:06PR Newswire (US)Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACRNASDAQ:KOSNKosan Biosciences (MM)
14/04/200808:00PR Newswire (US)Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung CancerNASDAQ:KOSNKosan Biosciences (MM)
28/03/200816:13Edgar (US Regulatory)Kosan Biosciences Inc - Securities Registration: Employee Benefit Plan (S-8)NASDAQ:KOSNKosan Biosciences (MM)
18/03/200819:45PR Newswire (US)Kosan Restructures Workforce to Focus Resources on Lead Clinical ProgramsNASDAQ:KOSNKosan Biosciences (MM)
18/03/200817:00PR Newswire (US)Kosan's Board of Directors Appoints Helen S. Kim as Chief Executive OfficerNASDAQ:KOSNKosan Biosciences (MM)
17/03/200817:53Edgar (US Regulatory)Kosan Biosciences Inc - Annual Report (10-K)NASDAQ:KOSNKosan Biosciences (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:KOSN

Seu Histórico Recente

NASDAQ
GFFFX
BIT
BSX
ETF
EU
WHATS
Whats Cooking Group NVSA
BIT
S29314
Societe Generale Effekten
BTRX
COTBTC
CosplayToken
BIT
P90487
Bnp Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados